American Century Companies
APGE icon

American Century Companies’s Apogee Therapeutics APGE Stock Holding History

American Century Companies’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,730
Closed -$454K – 2889
2024
Q3 		$454K Sell
7,730
-943
-11% -$45.2K ﹤0.01% 2507
2024
Q2 		$341K Buy
8,673
+2,199
+34% +$107K ﹤0.01% 2575
2024
Q1 		$430K Buy
+6,474
New +$283K ﹤0.01% 2500

Other funds holding APGE

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

American Century Companies's APGE Position: Q4 2024 in Review

American Century Companies sold out of Apogee Therapeutics (APGE) in Q4 2024, closing a stake of 7,730 shares — an estimated $454K sold.

American Century Companies first reported a position in APGE in Q1 2024 and held it in 3 quarters. The position peaked at $454K in Q3 2024. 157 funds tracked by Wall St. Rank hold APGE as of Q4 2024.

  • American Century Companies reported no remaining Apogee Therapeutics position as of Q4 2024 after selling out during the quarter.
  • American Century Companies sold 7,730 Apogee Therapeutics shares in Q4 2024, an estimated $454K.
  • American Century Companies first reported a position in Apogee Therapeutics in Q1 2024 and held it in 3 quarters.
  • American Century Companies's Apogee Therapeutics position peaked at $454K in Q3 2024.
  • 157 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q4 2024.

Based on American Century Companies's 13F filing for Q4 2024, filed 11 Feb 2025.